India's AstraZeneca Pharma jumps over 11% on Q4 profit jump
** AstraZeneca Pharma India ASTR.NS shares up 11.5% at 8,885 rupees, marking their biggest pct jump so far this year ** ASTR on Friday reported 48% surge in Q4 profit on strong performance of oncology and biopharma divisions ** AstraZeneca shares up 21.6% YTD vs 8.8% fall in Nifty pharma index .NIPHARM (Reporting by Sethuraman NR in Bengaluru) ((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net ))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication